SCHEMBL27180787

SCHEMBL27180787

O=C(Nc1cccc([N+](=O)[O-])c1)c1ccc(Br)c(S(=O)(=O)Nc2ccc(F)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.67
▸ KMT2A Q03164 9/20 0.67
▸ MAPT P10636 8/20 0.67
▸ LMNA P02545 6/20 0.67
▸ ALDH1A1 P00352 6/20 0.66
▸ SMN1; SMN2 Q16637 4/20 0.65
▸ POLB P06746 2/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ MAPK1 P28482 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ BLM P54132 1/20 0.55
▸ CASP3 P42574 1/20 0.54
▸ SENP8 Q96LD8 1/20 0.54
▸ SENP7 Q9BQF6 1/20 0.54
▸ SENP6 Q9GZR1 1/20 0.54
▸ NPC1 O15118 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180446 0.92 MEN1 (0.62) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27180114 0.92 MAPT (0.69) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179730 0.92 MAPT (0.72) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27180063 0.90 MEN1 (0.82) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179777 0.90 MAPT (0.67) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27180751 0.84 CASP3 (0.76) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30926647 0.84 CASP3 (0.76) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL27179757 0.83 LMNA (0.69) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30927043 0.83 LMNA (0.69) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL30926692 0.82 MAPT (0.85) MEN1KMT2AMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580404-A2 SULFONAMIDE APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 — — EP claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US claimed
WO-2024050041-A2 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 — — WO claimed
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPT 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback